Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TCF4 | P15884 | 5/20 | 0.71 |
| ▸ | CTNNB1 | P35222 | 5/20 | 0.71 |
| ▸ | CDH1 | P12830 | 1/20 | 0.71 |
| ▸ | APC | P25054 | 1/20 | 0.71 |
| ▸ | TCF7L2 | Q9NQB0 | 1/20 | 0.71 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | P4HB | P07237 | 3/20 | 0.33 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.33 |
| ▸ | SMAD3 | P84022 | 3/20 | 0.33 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cercosporin SCHEMBL29613349 | 1.00 | TCF4 (0.71) | TCF4CTNNB1CDH1APCTCF7L2 | |
| Cercosporin SCHEMBL6305985 | 1.00 | TCF4 (0.71) | TCF4CTNNB1CDH1APCTCF7L2 | |
| Cercosporin SCHEMBL15185706 | 1.00 | TCF4 (0.71) | TCF4CTNNB1CDH1APCTCF7L2 | |
| Cercosporin SCHEMBL28102616 | 0.99 | TCF4 (0.70) | TCF4CTNNB1CDH1APCTCF7L2 | |
| Cercosporin SCHEMBL21175561 | 0.94 | TCF4 (0.65) | TCF4CTNNB1CDH1APCTCF7L2 | |
| SCHEMBL22930428 | 0.94 | TCF4 (0.64) | TCF4CTNNB1CDH1APCTCF7L2 | |
| SCHEMBL29369377 | 0.83 | CTNNB1 (1.00) | TCF4CTNNB1CDH1APCTCF7L2 | |
| SCHEMBL13121634 | 0.81 | CTNNB1 (0.49) | TCF4CTNNB1CDH1APCTCF7L2 | |
| SCHEMBL8476647 | 0.71 | TCF4 (0.42) | TCF4CTNNB1CDH1APCTCF7L2 | |
| SCHEMBL29711267 | 0.66 | CTNNB1 (0.68) | TCF4CTNNB1CDH1APCTCF7L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 644 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4007582-B1 | ANTIBIOTICS IN COMBINATION WITH PHOTODYNAMIC THERAPY FOR USE IN A METHOD OF ENHANCING THE ANTIMICROBIAL ACTION OF SYSTEMICALLY ADMINISTERED ANTIBIOTICS | KOITE HEALTH OY (FI) | 2026-05-20 | — | — | EP | claimed |
| US-20260131003-A1 | Method and kit for treating skin infections | KOITE HEALTH OY (FI) | 2026-05-14 | — | — | US | claimed |
| EP-4255560-B1 | KIT FOR TREATMENT OF PATIENTS HAVING DRY MOUTH SYNDROME | KOITE HEALTH OY (FI) | 2026-04-22 | — | — | EP | claimed |
| US-12606649-B2 | Process for preparation of polyisobutene derivatives | BASF SE (DE) | 2026-04-21 | — | — | US | claimed |
| US-12521436-B2 | Method and kit for treating skin infections | KOITE HEALTH OY (FI) | 2026-01-13 | — | — | US | claimed |
| US-20250296906-A1 | METHOD FOR PREPARING 4-HYDROXY-2-METHYLENE-BUTANAL, 4-HYDROXY-2-METHYL-BUT-2-ENAL AND ESTERS THEREOF | BASF SE (DE) | 2025-09-25 | — | — | US | claimed |
| EP-4577516-A1 | METHOD FOR PREPARING 4-HYDROXY-2-METHYLENE-BUTANAL, 4-HYDROXY-2-METHYL-BUT-2-ENAL AND ESTERS THEREOF | BASF SE (DE) | 2025-07-02 | — | — | EP | claimed |
| EP-4577517-A1 | METHOD FOR PREPARING 4-HYDROXY-2-METHYLENE-BUTANAL, 4-HYDROXY-2-METHYL-BUT-2-ENAL AND ESTERS THEREOF | BASF SE (DE) | 2025-07-02 | — | — | EP | claimed |
| CN-119744258-A | Process for the preparation of 4-hydroxy-2-methylene-butyraldehyde, 4-hydroxy-2-methyl-but-2-enal and their esters | 巴斯夫欧洲公司 | 2025-04-01 | — | — | CN | claimed |
| CN-119744259-A | Process for the preparation of 4-hydroxy-2-methylene-butyraldehyde, 4-hydroxy-2-methyl-but-2-enal and their esters | 巴斯夫欧洲公司 | 2025-04-01 | — | — | CN | claimed |
| EP-0934401-A1 | FUNGAL GENE ENCODING RESISTANCE TO THE PHYTOTOXIN CERCOSPORIN | The United States of America, represented by The Secretary of Agriculture (US) | 1999-08-11 | — | — | EP | claimed |
| WO-1998041082-A9 | ISOLATED GENES AND PROTEINS ENCODING RESISTANCE TO PHOTOSENSITIZERS | — | 1999-03-04 | — | — | WO | claimed |
| WO-1998041612-A1 | CERCOSPORIN-DEGRADING BACTERIA | NORTH CAROLINA STATE UNIVERSITY (US) | 1998-09-24 | — | — | WO | claimed |
| WO-1998041082-A1 | ISOLATED GENES AND PROTEINS ENCODING RESISTANCE TO PHOTOSENSITIZERS | NORTH CAROLINA STATE UNIVERSITY (US) | 1998-09-24 | — | — | WO | claimed |
| WO-1998033470-A2 | SUBSTITUTED PERYLENEQUINONES FOR USE IN PHOTODYNAMIC THERAPY | ALTAREX CORP. (CA) | 1998-08-06 | — | — | WO | claimed |
| WO-1997035001-A1 | FUNGAL GENE ENCODING RESISTANCE TO THE PHYTOTOXIN CERCOSPORIN | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1997-09-25 | — | — | WO | claimed |
| CN-1143070-A | Photochemical method for preparation of 13-Cis retinoic acid | LAB MAG SPA (IT) | 1997-02-19 | — | — | CN | claimed |
| EP-0742204-A1 | Photochemical method for the preparation of 13-cis-retinoic acid | LABORATORI MAG S.p.A. (IT) | 1996-11-13 | — | — | EP | claimed |
| US-5262306-A | Degradation of cercosporin fungi by culturing microbes in agar and detection and extraction | NOVARTIS AG (CH) | 1993-11-16 | — | — | US | claimed |
| WO-1991005061-A1 | METHODS FOR IDENTIFYING CERCOSPORIN-DEGRADING MICROORGANISMS AND PRODUCING CERCOSPORIN-RESISTANT PLANT SPECIES | THE PLANT CELL RESEARCH INSTITUTE INCORPORATED (US) | 1991-04-18 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296906-A1 | METHOD FOR PREPARING 4-HYDROXY-2-METHYLENE-BUTANAL, 4-HYDROXY-2-METHYL-BUT-2-ENAL AND ESTERS THEREOF | ALDH1A2, ADH4, RBP4 | TCF4 1309/4885CTNNB1 1282/4885CDH1 2707/4885 |
| US-12606649-B2 | Process for preparation of polyisobutene derivatives | TCP1, POLD1, VAPA | TCF4 2592/4885CTNNB1 48/4885CDH1 1115/4885 |
| US-20260131003-A1 | Method and kit for treating skin infections | CUTA, KIT, FLNB | TCF4 1537/4885CTNNB1 141/4885CDH1 281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.